← Leaderboards
Rizia Bardhan
Iowa State University
$1,624,189
Attributed
$1,624,189
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $531.2K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,624,189 · 2
By mechanism
R01$1,201,558 · 1
R21$422,631 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Biological Markers”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,644,754
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,375,181
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,483,553
- Leonard Freedmand · Leidos Biomedical Research, Inc.$64,555,721
- Yunda Huang · Fred Hutchinson Cancer Center$54,118,126
- Susan Abushakra · Alzheon, Inc.$50,765,244
Research focus
Biological MarkersInnovationRaman Spectrum AnalysisClinical TrialsResponseMultiplex DetectionLabelNanoparticleScreeningSurfaceSpecificityDetectionClinically RelevantNanogoldHeterogeneityAnti-Pd-L1 TherapyAnti-Pd-L1DoseAntibodiesDisease ModelEarly DiagnosisAlternative TreatmentAftercareBinding
Grant awards (6)
Developing Multimodal Multiplexed ImmunoPET-Raman Probes to Guide Immunotherapies$266,335
R01 · FY2024 · EB · contact PI
Developing Multimodal Multiplexed ImmunoPET-Raman Probes to Guide Immunotherapies$296,095
R01 · FY2023 · EB · contact PI
Developing Multimodal Multiplexed ImmunoPET-Raman Probes to Guide Immunotherapies$311,158
R01 · FY2021 · EB · contact PI
PRADA: Portable Reusable Accurate Diagnostics with nanoAntennas for Multiplexed Biomarker Screening of Preterm Labor$220,049
R21 · FY2021 · HD · contact PI
Developing Multimodal Multiplexed ImmunoPET-Raman Probes to Guide Immunotherapies$327,970
R01 · FY2020 · EB · contact PI
PRADA: Portable Reusable Accurate Diagnostics with nanoAntennas for Multiplexed Biomarker Screening of Preterm Labor$202,582
R21 · FY2020 · HD · contact PI